Molecular Partners AG ADR (MOLN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.91
• Market Cap: $188.87M
• EPS: $-2.09
• 52-Week High: $5.11
• 52-Week Low: $3.36

Market Sentiment

Molecular Partners AG ADR currently has a Neutral sentiment score of 0.11.

About Molecular Partners AG ADR

Molecular Partners AG (MOLN) is an innovative clinical-stage biopharmaceutical company based in Schlieren, Switzerland, focusing on the development of novel protein-based therapeutics targeting oncology and viral infections. The company leverages its proprietary Darpin and Drug Conjugate technology platforms to design targeted therapies that enhance efficacy while minimizing side effects. With a promising clinical pipeline aimed at addressing critical unmet medical needs, Molecular Partners i...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Molecular Partners AG ADR and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does MOLN pay dividends?

Molecular Partners AG ADR (MOLN) does not currently pay a regular dividend.

What is MOLN's market cap?

Molecular Partners AG ADR (MOLN) has a market capitalization of $188.87M with a current stock price of $4.91.